Literature DB >> 15296962

The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics.

Wolfgang Fraunhofer1, Gerhard Winter.   

Abstract

Field-flow fractionation (FFF) is a family of flexible analytical fractionating techniques which have the advantage that the separation of analytes is achieved, solely through the interaction of the sample with an external, perpendicular physical field, rather than by the interaction with a stationary phase. The rapid progress in pharmaceutical biotechnology goes along with an increasing demand in potent, high-efficient analytical methods. Thus, FFF techniques are gaining increasing attention for their ability to separate and characterize populations of polymers, colloids and particles of up to about 100 microm in size. It is the intention of this review to provide an overview on common FFF techniques, to summarize inherent advantages and limitations and to introduce both established and challenging applications in the (bio)pharmaceutical field. Thereby, asymmetrical flow FFF is addressed predominantly, since it is the most versatile applicable FFF technique.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15296962     DOI: 10.1016/j.ejpb.2004.03.034

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  20 in total

1.  Impact of carrier fluid composition on recovery of nanoparticles and proteins in flow field flow fractionation.

Authors:  Samantha Schachermeyer; Jonathan Ashby; Minjung Kwon; Wenwan Zhong
Journal:  J Chromatogr A       Date:  2012-09-26       Impact factor: 4.759

2.  Taylor dispersion analysis compared to dynamic light scattering for the size analysis of therapeutic peptides and proteins and their aggregates.

Authors:  Andrea Hawe; Wendy L Hulse; Wim Jiskoot; Robert T Forbes
Journal:  Pharm Res       Date:  2011-05-11       Impact factor: 4.200

3.  In situ microfluidic dialysis for biological small-angle X-ray scattering.

Authors:  Magda Skou; Søren Skou; Thomas G Jensen; Bente Vestergaard; Richard E Gillilan
Journal:  J Appl Crystallogr       Date:  2014-08-01       Impact factor: 3.304

4.  Rapid, quantitative determination of aggregation and particle formation for antibody drug conjugate therapeutics with label-free Raman spectroscopy.

Authors:  Chi Zhang; Jeremy S Springall; Xiangyang Wang; Ishan Barman
Journal:  Anal Chim Acta       Date:  2019-07-10       Impact factor: 6.558

5.  Breaking the aggregation of the monoclonal antibody bevacizumab (avastin®) by dexamethasone phosphate: insights from molecular modelling and asymmetrical flow field-flow fractionation.

Authors:  Marieke Veurink; Yvonne Westermaier; Robert Gurny; Leonardo Scapozza
Journal:  Pharm Res       Date:  2013-02-15       Impact factor: 4.200

6.  Polymorphic fibrillation of the destabilized fourth fasciclin-1 domain mutant A546T of the Transforming growth factor-β-induced protein (TGFBIp) occurs through multiple pathways with different oligomeric intermediates.

Authors:  Maria Andreasen; Søren B Nielsen; Kasper Runager; Gunna Christiansen; Niels Chr Nielsen; Jan J Enghild; Daniel E Otzen
Journal:  J Biol Chem       Date:  2012-08-14       Impact factor: 5.157

7.  A bayesian approach for quantifying trace amounts of antibody aggregates by sedimentation velocity analytical ultracentrifugation.

Authors:  Patrick H Brown; Andrea Balbo; Peter Schuck
Journal:  AAPS J       Date:  2008-09-24       Impact factor: 4.009

8.  Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres.

Authors:  Catia Contado; Alessandro Dalpiaz; Eliana Leo; Maciej Zborowski; P Stephen Williams
Journal:  J Chromatogr A       Date:  2007-04-21       Impact factor: 4.759

9.  Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.

Authors:  Haiying Zhang; Daniela Freitas; Han Sang Kim; Kristina Fabijanic; Zhong Li; Haiyan Chen; Milica Tesic Mark; Henrik Molina; Alberto Benito Martin; Linda Bojmar; Justin Fang; Sham Rampersaud; Ayuko Hoshino; Irina Matei; Candia M Kenific; Miho Nakajima; Anders Peter Mutvei; Pasquale Sansone; Weston Buehring; Huajuan Wang; Juan Pablo Jimenez; Leona Cohen-Gould; Navid Paknejad; Matthew Brendel; Katia Manova-Todorova; Ana Magalhães; José Alexandre Ferreira; Hugo Osório; André M Silva; Ashish Massey; Juan R Cubillos-Ruiz; Giuseppe Galletti; Paraskevi Giannakakou; Ana Maria Cuervo; John Blenis; Robert Schwartz; Mary Sue Brady; Héctor Peinado; Jacqueline Bromberg; Hiroshi Matsui; Celso A Reis; David Lyden
Journal:  Nat Cell Biol       Date:  2018-02-19       Impact factor: 28.824

10.  Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particles.

Authors:  Craig D Blanchette; Brent W Segelke; Nicholas Fischer; Michele H Corzett; Edward A Kuhn; Jenny A Cappuccio; William Henry Benner; Matthew A Coleman; Brett A Chromy; Graham Bench; Paul D Hoeprich; Todd A Sulchek
Journal:  Int J Mol Sci       Date:  2009-07-02       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.